Laura Borgelt, PharmD, FCCP, BCPS
Professor and Associate Dean of Administration and Operations
University of Colorado Skaggs School of Pharmacy
Nurse practitioners (NPs), Certified Nurse-Midwives (CNMs), and other advanced practice clinicians who care for women.
- CE Approval Period: Now through December 2019
- Estimated Time to Complete This Activity: .75 hours
- CE Approval Hours: .75 Contact Hours of CE Credit including .75 hours of pharmacology credit.
At the conclusion of this activity, clinicians should be better able to:
- Describe the clinical pharmacology of cannabis and important factors related to women.
- Evaluate the pharmacokinetics of various cannabis formulations.
- Explain communication strategies for discussing cannabis use with women that are pregnant, lactating, or using medical cannabis for other reasons.
Successful Completion of the Activity:
Successful completion of this online activity, 18-04-03, requires the participant to:
During the approval period (now through December 2019);
- Read the educational objectives, disclosures, and disclaimers on the front page;
- Study the material in the learning activity by watching the session;
- Complete the post test with a score of 70% or higher;
- Complete the session evaluation;
- After successful completion you may print your CE certificate. Your certificate will be stored for you on the NPWH E-Learning site under My Transcripts
Thirty U.S. states and the District of Columbia have laws that allow marijuana to be used for medicinal reasons; eight of those states have also passed laws for recreational use. Pregnant and breastfeeding women may resort to using marijuana to alleviate nausea and vomiting, improve sleep, treat other medical conditions, or use it recreationally. Cannabis has also been used in women experiencing pelvic pain or autoimmune disorders. It is important for providers to understand the characteristics of marijuana, including therapeutic effects, potential side effects, drug interactions, dosage forms, and patient safety issues. Providers need to know how to communicate with women about the risks and benefits of using marijuana.
This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health (NPWH), and has been approved for .75 contact hour(s) of CE credit and .75 hours of pharmacology credit. Each participant should claim only those contact hours that he/she actually spent in the educational activity.
Activity Number: 18-04-03
NPWH policy requires all faculty to disclose any affiliation or relationship with a commercial interest that may cause a potential, real, or apparent conflict of interest with the content of a CE program. NPWH does not imply that the affiliation or relationship will affect the content of the CE program. Disclosure provides participants with information that may be important to their evaluation of an activity. All conflicts of interest were resolved according to NPWH policy. In addition, all content has been peer reviewed by a WHNP with no conflicts of interest to ensure the content is evidence-based, un-biased, and uses the best available, highest strength evidence for recommendations. Faculty are also asked to identify any unlabeled/unapproved uses of drugs or devices made in their presentation.
Laura Borgelt, PharmD, FCCP, BCPS has nothing to disclose.
Disclosure of unlabeled use:
NPWH policy requires authors to disclose to participants when presenting information about unlabeled use of a commercial product or device or an investigational use of a drug or device not yet approved for any use.
Participating faculty members determine the editorial content of CE activities; this content does not necessarily represent the views of NPWH. This content has undergone a blinded peer review process for validation of clinical content. Although every effort has been made to ensure that the information is accurate, clinicians are responsible for evaluating this information in relation to generally accepted standards in their own communities and integrating the information in this activity with that of established recommendations of other authorities, national guidelines, FDA approved package inserts, and individual patient characteristics.
There was no commercial support provided for this activity.
You must be signed in to access this course. You can sign in at the top right-hand corner of the page.
**If you are an NPWH member, were once a member, or have taken CE activities with NPWH in the past, you have a username and password in our new system. Please DO NOT create a new account. Creation of multiple accounts could result in loss of CE credits as well as other NPWH services. If you do not remember your username or password, please either click on the "forgot username" or "forgot password" links at the bottom of the sign in screen or call the NPWH office at (202) 543-9693 ext. 1.**